Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MTP-5019 data revealed at AACR

May 3, 1996

Onco TCS slated to enter phase II

May 3, 1996

AG-2034 data reported at AACR

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

GBC590 progresses to toxicity testing

April 26, 1996

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Topotecan approval recommended

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...